Title: Why won’t this bacterial infection go away? - Daily Monitor
Headings: Why won’t this bacterial infection go away?
Why won’t this bacterial infection go away?
Summary

Content: “Most of these innovator drugs are coming from the European world,” Mr Opio says. “ They look at the viability, the market. What market are they looking for? The European and US market. And what are the diseases there? Obesity. That is where they will put their money. But is obesity a big problem here?” he asks. The problem of antibiotics resistance has been steadily growing in Uganda, with research by the Alliance for Prudent Use of Antibiotics stating that resistance to Cotrimoxazole (Septrin) rose from 10 per cent in 2001 to 90 per cent in 2007.